Direct answer: A peptide name is only a starting point. A purchase specification should reconcile sequence, modifications, terminal groups, counterion or salt form, registry identifiers, and the actual supplied format before a buyer compares batches or quotes.
Technical editorial review: 22 October 2026. Confirm current standards, market rules and batch records before purchase.
Why a familiar peptide name is not a complete identity
Two catalog entries can share a familiar peptide name and still refer to different purchasable materials. The sequence may be the same while a terminal modification, salt or counterion, hydration state, or mixture composition differs. A CAS number helps search for a substance, but it should not replace the supplier’s signed description of the material being shipped. FDA’s Global Substance Registration System uses Unique Ingredient Identifiers to support unambiguous substance exchange in regulated-product data; a registry record is an identity aid, not proof that a particular batch has passed release testing. Procurement teams should therefore keep separate fields for the intended structure, the commercial form, and the batch evidence. If a supplier quotes only a common name, request the sequence and modification notation, stated salt form, relevant identifier and analytical method before comparing price or purity. Treat a missing identifier as an open technical question rather than guessing from a search result.
Identity fields to reconcile
- Common and systematic names used in the inquiry and quotation
- Sequence, terminal groups and any declared modifications
- Counterion or salt form, hydration state and relevant mixture information
- CAS or UNII where appropriate, with the matching source record
- Batch identifier, packaging label and signed specification version
How to connect identity documents to the offered batch
The purchasing trail should connect the RFQ, quotation, specification, label and certificate of analysis to one defined material. Ask whether a reported molecular mass describes the neutral sequence, a salt, a hydrate or another measured species; unexplained differences can cause false comparisons. Mass spectrometry may support identity under the stated method, but it does not alone establish content, impurity limits or packaging suitability. A chromatogram also needs its method, reference, integration rules and acceptance criteria to be interpretable. Record which document is a generic sample and which names the actual lot. For a custom sequence, the approved sequence and modification map should be version-controlled before sampling and again before commercial release. If two records disagree on a salt, terminal group or lot code, stop the comparison and request a corrected, traceable document set. This prevents a search-friendly product name from becoming an unsupported purchasing specification.
Five-document cross-check
- RFQ: intended identity and end-use category
- Quotation: precise offered form and quantity
- Specification: identity tests and acceptance criteria
- COA: actual lot results with method references
- Label: matching name, lot, net quantity and storage statement
What to ask when a catalog field is blank
A blank field is safer than an invented value, but it should still lead to a specific buyer question. If the CAS number is missing, ask whether the product is represented by a different registered form and request the underlying identity record. If the formula or molecular weight is missing, ask the supplier which form the value would describe and whether it comes from a calculation or a validated measurement. For modified peptides, request an unambiguous sequence convention and a description of any nonstandard residue. For lyophilized product, also distinguish peptide identity from excipients and fill strength. These clarifications can be completed before a quote is accepted, while current-lot tests belong to release review. The site’s product pages show source-listed data where available and leave unresolved fields open for confirmation. Buyers can use the product catalog and structured RFQ form to send the exact field set needed for technical review.
RFQ wording that removes ambiguity
- “Please confirm the exact sequence and terminal modifications.”
- “Which salt or counterion does the quoted item contain?”
- “Does the stated molecular mass refer to the supplied form?”
- “Which identifier and batch document support this identity?”
Frequently asked questions
Is a CAS number enough to order a peptide?
No. Use it alongside the sequence, modifications, salt form, signed specification and batch-linked evidence.
Does a UNII prove a lot is compliant?
No. FDA describes UNIIs as substance identifiers; lot quality still depends on the agreed tests and release records.
What if the catalog and COA use different names?
Ask the supplier to reconcile the naming and lot traceability before approving the purchase.
References and scope
These primary sources define the cited concepts. Regulatory guidelines apply only within their stated scope; this article provides buyer questions and does not certify a particular material or lot.
Related: product catalog · quality review · all resources · request a project quote.